Coronavirus: Hajdu says Health Canada would need to approve change in Pfizer manufacturing site
Asked whether Pfizer could change its manufacturing site from Europe to the U.S. to lessen the delay in vaccine deliveries, Health Minister Patty Hajdu said a change in manufacturing sites would need approval from Health Canada.
UP NEXT
UP NEXT
-
Michael Kovrig’s wife says she hopes Biden’s ‘powerful’ words will lead to action
-
Biden calls on China to release Michael Kovrig, Michael Spavor
-
Trudeau questioned on cancellation of Keystone XL project, impacts of calls to shut down Enbridge’s Line 5
-
Health Canada green lights the AstraZeneca vaccine
-
Coronavirus: Canada secures 2M doses of CoviShield vaccine, to arrive in weeks
-
Tories want probe into commercial relief program
-
Taking on record debt during the pandemic? A finance expert shares tips and insights
-
Health officials warn about disinformation, conspiracies
-
Trudeau says government takes misconduct allegations against former top military officials ‘extremely seriously’
-
Trudeau grilled over military misconduct allegations
-
Earthlings solve NASA’s Perseverance parachute puzzle
-
Military reacts to another top Canadian soldier under investigation
-
Does delaying the second COVID-19 vaccine dose really save lives?
-
Health Canada approves Oxford-AstraZeneca’s COVID-19 vaccine
-
Coronavirus: Fortin provides update on vaccine deliveries in Canada
-
Coronavirus: Canada approves AstraZeneca and Serum Institute of India’s vaccines